Common Reasons for Stalled Weight Loss on GLP-1 medication When starting on a weight loss journey with GLP-1 medication, its important to maintain realistic expectations for gradual and sustainable progress
Upper blepharoplasty removes excess skin and sometimes fat from the upper eyelids, reducing drooping that can cause a tired or heavy-eyed appearance
You might recognize a plateau if your body weight remains unchanged for a few weeks, despite following your treatment plan and making lifestyle changes
doi: 10.1016/j.lfs.2013.01.001 47 KoehlerJAKainTDruckerDJ
you can also search for UK trials via NIHR Be Part of Research (www.bepartofresearch.nihr.ac.uk) Do not discontinue any existing prescribed medication (such as semaglutide or tirzepatide) in anticipation of retatrutide becoming available For clinicians: Familiarise yourself with the LY3437943 development code and ongoing Phase 3 trial data, as patients may present with questions informed by media coverage Be prepared to discuss the distinction between investigational and approved therapies , and the importance of evidence-based prescribing Monitor MHRA and NICE communications for updates on regulatory submissions and technology appraisals From a safety perspective, the adverse effect profile observed in Phase 2 trials (as reported in the 2023 New England Journal of Medicine publication) was broadly consistent with other GLP-1-based therapies, with nausea, vomiting, diarrhoea, and decreased appetite being the most commonly reported side effects
Review the testing policy before purchase
